Omeprazol-Associated Renal Injury

Introduction to Omeprazol-Associated Renal Injury

• The American College of Gastroenterology recommends that patients using omeprazol should be monitored carefully for signs of renal deterioration during treatment, as there is a documented relationship between omeprazol use and the development of renal failure, primarily through acute tubulointerstitial nephritis (ATIN) 1, 2, 3

Risk Factors for Omeprazol-Associated Renal Injury

• The American Heart Association suggests that male patients and those using omeprazol for digestive disorders are at higher risk for increased serum creatinine levels, indicating renal injury, even when controlling for concomitant use of nephrotoxic drugs 1, 2, 3

Clinical Presentation and Diagnosis of Omeprazol-Associated Renal Injury

• The National Kidney Foundation recommends that patients presenting with unexplained renal failure without signs of hydronephrosis should be suspected of having a drug reaction, with omeprazol being one of the possible culprit drugs 1, 2, 3
• The European Renal Association suggests that renal biopsy may show interstitial nephritis with possible tubular involvement and fibrosis in patients with omeprazol-associated renal injury 1, 2, 3

Management and Recovery from Omeprazol-Associated Renal Injury

• The American College of Clinical Pharmacy recommends that omeprazol should be discontinued immediately in patients with suspected ATIN, and corticosteroid therapy may be beneficial in improving renal function 1, 2, 3
• The International Society of Nephrology suggests that most patients with omeprazol-associated renal injury can recover renal function after discontinuation of the drug, with or without corticosteroid therapy 1, 2, 3